Madavan Bindu

Madavan Bindu is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tuberculosis. His innovative approach has led to the development of a unique antitubercular composition.

Latest Patents

Madavan Bindu holds 1 patent for his invention titled "Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation." This invention relates to a monolayer tablet designed for the treatment of tuberculosis. The tablet comprises a mixture of granules containing isoniazid, pyrazinamide, ethambutol, or a pharmaceutically acceptable salt thereof, along with rifampicin in powder form and extragranular excipients. The granules are specifically formulated to have a particle size of less than 0.599 mm, enhancing the effectiveness of the treatment.

Career Highlights

Madavan Bindu is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative solutions for complex health issues, particularly in infectious diseases. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.

Collaborations

Madavan has collaborated with several professionals in his field, including Kumar Amith and Prasad Kum. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of his research.

Conclusion

Madavan Bindu's contributions to the field of pharmaceuticals, particularly in tuberculosis treatment, highlight his innovative spirit and dedication to improving healthcare. His patent reflects a significant advancement in the formulation of antitubercular medications.

Profile summary based on public USPTO records.